For over a decade, countless patients with extensive, chronic gastrointestinal complaints have found their way to my clinical nutrition practice believing that “systemic candida” — or, a pervasive ...

Invasive Candida infections remain an important cause of morbidity and mortality, especially in hospitalized and immunocompromised or critically ill patients. A limited number of antifungal agents ...

In a recent Science Advances study, scientists have developed a novel nanozyme-probiotic combination therapy for Candida vaginitis, which shows potency in killing the causative pathogen, restoring ...

Symptoms of Candida overgrowth include mouth lesions, fatigue, and digestive issues. Addressing the underlying cause can help ease symptoms and prevent recurring infections. Candida is typically found ...

Credit: Melinta Therapeutics. Rezzayo is supplied as a solid (cake or powder) in a single-dose vial containing 200mg of rezafungin. Rezzayo ™ (rezafungin for injection) is now available for the ...

Approval based on positive results from the pivotal ReSTORE Phase III clinical trial and supported by the STRIVE Phase II clinical trials and extensive nonclinical development program. REZZAYO ...

Background: Invasive candidiasis is increasingly prevalent in premature infants and seriously ill children, and pediatric data on available antifungal therapies are lacking. Methods: We conducted a ...

The FDA’s advisory committee on antimicrobial drugs on Jan. 25 recommended rezafungin be approved to treat candidemia and invasive candidiasis in adults with limited or no alternative treatment option ...

Women: If you’ve ever had a burning or itching sensation or thick discharge down below, then you likely know the discomfort and frustration of a yeast infection. According to the Office on Women’s ...